Human cytotoxic T-lymphocyte repertoire to influenza A viruses.
Identifieur interne : 000381 ( PubMed/Curation ); précédent : 000380; suivant : 000382Human cytotoxic T-lymphocyte repertoire to influenza A viruses.
Auteurs : J. Jameson [États-Unis] ; J. Cruz ; F A EnnisSource :
- Journal of virology [ 0022-538X ] ; 1998.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Antigènes HLA, Antigènes viraux, Cartographie épitopique, Humains, Interféron gamma (biosynthèse), Lignée cellulaire, Lymphocytes T cytotoxiques (immunologie), Mémoire immunologique, Protéines de la matrice virale (immunologie), Protéines virales (immunologie), Réactions croisées, Sialidase (immunologie), Souris, Techniques in vitro, Virus de la grippe A (), Virus de la grippe A (immunologie), Épitopes.
- MESH :
- biosynthèse : Interféron gamma.
- immunologie : Lymphocytes T cytotoxiques, Protéines de la matrice virale, Protéines virales, Sialidase, Virus de la grippe A.
- Adulte, Animaux, Antigènes HLA, Antigènes viraux, Cartographie épitopique, Humains, Lignée cellulaire, Mémoire immunologique, Réactions croisées, Souris, Techniques in vitro, Virus de la grippe A, Épitopes.
English descriptors
- KwdEn :
- Adult, Animals, Antigens, Viral, Cell Line, Cross Reactions, Epitope Mapping, Epitopes, HLA Antigens, Humans, Immunologic Memory, In Vitro Techniques, Influenza A virus (classification), Influenza A virus (immunology), Interferon-gamma (biosynthesis), Mice, Neuraminidase (immunology), T-Lymphocytes, Cytotoxic (immunology), Viral Matrix Proteins (immunology), Viral Proteins (immunology).
- MESH :
- chemical , biosynthesis : Interferon-gamma.
- chemical , immunology : Neuraminidase, Viral Matrix Proteins, Viral Proteins.
- chemical : Antigens, Viral, Epitopes, HLA Antigens.
- classification : Influenza A virus.
- immunology : Influenza A virus, T-Lymphocytes, Cytotoxic.
- Adult, Animals, Cell Line, Cross Reactions, Epitope Mapping, Humans, Immunologic Memory, In Vitro Techniques, Mice.
Abstract
The murine CD8(+) cytotoxic-T-lymphocyte (CTL) repertoire appears to be quite limited in response to influenza A viruses. The CTL responses to influenza A virus in humans were examined to determine if the CTL repertoire is also very limited. Bulk cultures revealed that a number of virus proteins were recognized in CTL assays. CTL lines were isolated from three donors for detailed study and found to be specific for epitopes on numerous influenza A viral proteins. Eight distinct CD8(+) CTL lines were isolated from donor 1. The proteins recognized by these cell lines included the nucleoprotein (NP), matrix protein (M1), nonstructural protein 1 (NS1), polymerases (PB1 and PB2), and hemagglutinin (HA). Two CD4(+) cell lines, one specific for neuraminidase (NA) and the other specific for M1, were also characterized. These CTL results were confirmed by precursor frequency analysis of peptide-specific gamma interferon-producing cells detected by ELISPOT. The epitopes recognized by 6 of these 10 cell lines have not been previously described; 8 of the 10 cell lines were cross-reactive to subtype H1N1, H2N2, and H3N2 viruses, 1 cell line was cross-reactive to subtypes H1N1 and H2N2, and 1 cell line was subtype H1N1 specific. A broad CTL repertoire was detected in the two other donors, and cell lines specific for the NP, NA, HA, M1, NS1, and M2 viral proteins were isolated. These findings indicate that the human memory CTL response to influenza A virus is broadly directed to epitopes on a wide variety of proteins, unlike the limited response observed following infection of mice.
PubMed: 9765409
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000381
Links to Exploration step
pubmed:9765409Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human cytotoxic T-lymphocyte repertoire to influenza A viruses.</title><author><name sortKey="Jameson, J" sort="Jameson, J" uniqKey="Jameson J" first="J" last="Jameson">J. Jameson</name><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical Center, Worcester, Massachusetts 01655</wicri:regionArea></affiliation></author><author><name sortKey="Cruz, J" sort="Cruz, J" uniqKey="Cruz J" first="J" last="Cruz">J. Cruz</name></author><author><name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F A" last="Ennis">F A Ennis</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1998">1998</date><idno type="RBID">pubmed:9765409</idno><idno type="pmid">9765409</idno><idno type="wicri:Area/PubMed/Corpus">000381</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000381</idno><idno type="wicri:Area/PubMed/Curation">000381</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000381</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Human cytotoxic T-lymphocyte repertoire to influenza A viruses.</title><author><name sortKey="Jameson, J" sort="Jameson, J" uniqKey="Jameson J" first="J" last="Jameson">J. Jameson</name><affiliation wicri:level="1"><nlm:affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical Center, Worcester, Massachusetts 01655</wicri:regionArea></affiliation></author><author><name sortKey="Cruz, J" sort="Cruz, J" uniqKey="Cruz J" first="J" last="Cruz">J. Cruz</name></author><author><name sortKey="Ennis, F A" sort="Ennis, F A" uniqKey="Ennis F" first="F A" last="Ennis">F A Ennis</name></author></analytic><series><title level="j">Journal of virology</title><idno type="ISSN">0022-538X</idno><imprint><date when="1998" type="published">1998</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Animals</term><term>Antigens, Viral</term><term>Cell Line</term><term>Cross Reactions</term><term>Epitope Mapping</term><term>Epitopes</term><term>HLA Antigens</term><term>Humans</term><term>Immunologic Memory</term><term>In Vitro Techniques</term><term>Influenza A virus (classification)</term><term>Influenza A virus (immunology)</term><term>Interferon-gamma (biosynthesis)</term><term>Mice</term><term>Neuraminidase (immunology)</term><term>T-Lymphocytes, Cytotoxic (immunology)</term><term>Viral Matrix Proteins (immunology)</term><term>Viral Proteins (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Antigènes HLA</term><term>Antigènes viraux</term><term>Cartographie épitopique</term><term>Humains</term><term>Interféron gamma (biosynthèse)</term><term>Lignée cellulaire</term><term>Lymphocytes T cytotoxiques (immunologie)</term><term>Mémoire immunologique</term><term>Protéines de la matrice virale (immunologie)</term><term>Protéines virales (immunologie)</term><term>Réactions croisées</term><term>Sialidase (immunologie)</term><term>Souris</term><term>Techniques in vitro</term><term>Virus de la grippe A ()</term><term>Virus de la grippe A (immunologie)</term><term>Épitopes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Interferon-gamma</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Neuraminidase</term><term>Viral Matrix Proteins</term><term>Viral Proteins</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Antigens, Viral</term><term>Epitopes</term><term>HLA Antigens</term></keywords><keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Interféron gamma</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T cytotoxiques</term><term>Protéines de la matrice virale</term><term>Protéines virales</term><term>Sialidase</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>T-Lymphocytes, Cytotoxic</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Animals</term><term>Cell Line</term><term>Cross Reactions</term><term>Epitope Mapping</term><term>Humans</term><term>Immunologic Memory</term><term>In Vitro Techniques</term><term>Mice</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Antigènes HLA</term><term>Antigènes viraux</term><term>Cartographie épitopique</term><term>Humains</term><term>Lignée cellulaire</term><term>Mémoire immunologique</term><term>Réactions croisées</term><term>Souris</term><term>Techniques in vitro</term><term>Virus de la grippe A</term><term>Épitopes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The murine CD8(+) cytotoxic-T-lymphocyte (CTL) repertoire appears to be quite limited in response to influenza A viruses. The CTL responses to influenza A virus in humans were examined to determine if the CTL repertoire is also very limited. Bulk cultures revealed that a number of virus proteins were recognized in CTL assays. CTL lines were isolated from three donors for detailed study and found to be specific for epitopes on numerous influenza A viral proteins. Eight distinct CD8(+) CTL lines were isolated from donor 1. The proteins recognized by these cell lines included the nucleoprotein (NP), matrix protein (M1), nonstructural protein 1 (NS1), polymerases (PB1 and PB2), and hemagglutinin (HA). Two CD4(+) cell lines, one specific for neuraminidase (NA) and the other specific for M1, were also characterized. These CTL results were confirmed by precursor frequency analysis of peptide-specific gamma interferon-producing cells detected by ELISPOT. The epitopes recognized by 6 of these 10 cell lines have not been previously described; 8 of the 10 cell lines were cross-reactive to subtype H1N1, H2N2, and H3N2 viruses, 1 cell line was cross-reactive to subtypes H1N1 and H2N2, and 1 cell line was subtype H1N1 specific. A broad CTL repertoire was detected in the two other donors, and cell lines specific for the NP, NA, HA, M1, NS1, and M2 viral proteins were isolated. These findings indicate that the human memory CTL response to influenza A virus is broadly directed to epitopes on a wide variety of proteins, unlike the limited response observed following infection of mice.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9765409</PMID><DateCompleted><Year>1998</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>72</Volume><Issue>11</Issue><PubDate><Year>1998</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J. Virol.</ISOAbbreviation></Journal><ArticleTitle>Human cytotoxic T-lymphocyte repertoire to influenza A viruses.</ArticleTitle><Pagination><MedlinePgn>8682-9</MedlinePgn></Pagination><Abstract><AbstractText>The murine CD8(+) cytotoxic-T-lymphocyte (CTL) repertoire appears to be quite limited in response to influenza A viruses. The CTL responses to influenza A virus in humans were examined to determine if the CTL repertoire is also very limited. Bulk cultures revealed that a number of virus proteins were recognized in CTL assays. CTL lines were isolated from three donors for detailed study and found to be specific for epitopes on numerous influenza A viral proteins. Eight distinct CD8(+) CTL lines were isolated from donor 1. The proteins recognized by these cell lines included the nucleoprotein (NP), matrix protein (M1), nonstructural protein 1 (NS1), polymerases (PB1 and PB2), and hemagglutinin (HA). Two CD4(+) cell lines, one specific for neuraminidase (NA) and the other specific for M1, were also characterized. These CTL results were confirmed by precursor frequency analysis of peptide-specific gamma interferon-producing cells detected by ELISPOT. The epitopes recognized by 6 of these 10 cell lines have not been previously described; 8 of the 10 cell lines were cross-reactive to subtype H1N1, H2N2, and H3N2 viruses, 1 cell line was cross-reactive to subtypes H1N1 and H2N2, and 1 cell line was subtype H1N1 specific. A broad CTL repertoire was detected in the two other donors, and cell lines specific for the NP, NA, HA, M1, NS1, and M2 viral proteins were isolated. These findings indicate that the human memory CTL response to influenza A virus is broadly directed to epitopes on a wide variety of proteins, unlike the limited response observed following infection of mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jameson</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ennis</LastName><ForeName>F A</ForeName><Initials>FA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007349</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI 07349</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber><NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1998</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1998</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1998</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9765409</ArticleId><ArticleId IdType="pmc">PMC110281</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scand J Clin Lab Invest Suppl. 1968;97:77-89</Citation><ArticleIdList><ArticleId IdType="pubmed">4179068</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1989 Dec;63(12):5086-91</Citation><ArticleIdList><ArticleId IdType="pubmed">2511337</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1977 Sep;7(9):630-5</Citation><ArticleIdList><ArticleId IdType="pubmed">303568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1978 May 18;273(5659):238-9</Citation><ArticleIdList><ArticleId IdType="pubmed">306072</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1979 Mar;76(3):1425-9</Citation><ArticleIdList><ArticleId IdType="pubmed">86990</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1990 Sep;178(1):174-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1697125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1990 Nov 15;348(6298):213-6</Citation><ArticleIdList><ArticleId IdType="pubmed">1700303</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1990;2(4):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2126195</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 1991 May 22;244(1310):169-77</Citation><ArticleIdList><ArticleId IdType="pubmed">1715994</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1991 Oct 15;147(8):2677-84</Citation><ArticleIdList><ArticleId IdType="pubmed">1717572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1991 Oct 1;174(4):875-80</Citation><ArticleIdList><ArticleId IdType="pubmed">1919440</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1992 Feb 1;148(3):894-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1370522</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1992 Apr 1;175(4):1143-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1552285</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1993 Feb;23(2):447-53</Citation><ArticleIdList><ArticleId IdType="pubmed">7679646</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1977 Mar 1;145(3):557-68</Citation><ArticleIdList><ArticleId IdType="pubmed">233901</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1993 Oct;67(10):5962-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8371350</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1993 Dec 1;151(11):5930-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7504010</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1994 May 15;152(10):4843-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8176207</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 1994;189:35-63</Citation><ArticleIdList><ArticleId IdType="pubmed">7523033</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1995 Apr;7(4):597-605</Citation><ArticleIdList><ArticleId IdType="pubmed">7547687</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1996 Oct 1;157(7):3039-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8816413</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1996 Dec 15;157(12):5555-62</Citation><ArticleIdList><ArticleId IdType="pubmed">8955206</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1997 Jun;9(6):815-23</Citation><ArticleIdList><ArticleId IdType="pubmed">9199964</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1997 Jul 21;234(1):62-73</Citation><ArticleIdList><ArticleId IdType="pubmed">9234947</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1997 Sep 15;186(6):859-65</Citation><ArticleIdList><ArticleId IdType="pubmed">9294140</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 1998 Feb;8(2):177-87</Citation><ArticleIdList><ArticleId IdType="pubmed">9491999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Infect Dis. 1980 May-Jun;2(3):408-20</Citation><ArticleIdList><ArticleId IdType="pubmed">6997968</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1981 Mar;126(3):1036-41</Citation><ArticleIdList><ArticleId IdType="pubmed">6970211</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1981 Mar;126(3):1042-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7462625</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1981 Apr 1;153(4):910-23</Citation><ArticleIdList><ArticleId IdType="pubmed">6166708</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1981 Aug 1;154(2):225-34</Citation><ArticleIdList><ArticleId IdType="pubmed">6267157</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1982 Mar;128(3):1428-32</Citation><ArticleIdList><ArticleId IdType="pubmed">6173437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1982 Mar 4;296(5852):75-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6278312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1982 Nov 4;300(5887):66-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6982419</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1983 Jul 7;309(1):13-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6602294</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1984 Sep 1;160(3):814-26</Citation><ArticleIdList><ArticleId IdType="pubmed">6206190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1984 Nov;39(1):13-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6091906</ArticleId></ArticleIdList></Reference><Reference><Citation>Prog Allergy. 1985;36:10-43</Citation><ArticleIdList><ArticleId IdType="pubmed">3881777</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3872457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1985 Sep;94(2):394-405</Citation><ArticleIdList><ArticleId IdType="pubmed">2411429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1986 Mar 28;44(6):959-68</Citation><ArticleIdList><ArticleId IdType="pubmed">2420472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1986 Apr;67 ( Pt 4):719-26</Citation><ArticleIdList><ArticleId IdType="pubmed">3485697</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunogenetics. 1986;23(6):379-84</Citation><ArticleIdList><ArticleId IdType="pubmed">3487504</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1986 Aug 1;137(3):995-1002</Citation><ArticleIdList><ArticleId IdType="pubmed">2424996</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1986 Nov 1;164(5):1397-406</Citation><ArticleIdList><ArticleId IdType="pubmed">2430041</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1987 Feb 1;165(2):408-16</Citation><ArticleIdList><ArticleId IdType="pubmed">3029268</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1987 Apr;61(4):1098-102</Citation><ArticleIdList><ArticleId IdType="pubmed">3493353</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1987 Apr 30-May 6;326(6116):881-2</Citation><ArticleIdList><ArticleId IdType="pubmed">2437457</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1987 Oct;160(2):336-45</Citation><ArticleIdList><ArticleId IdType="pubmed">3310381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1988 Feb 26;52(4):515-23</Citation><ArticleIdList><ArticleId IdType="pubmed">2963699</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1988 Feb 15;140(4):1264-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2449498</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1988 Nov 1;168(5):1935-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3263469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1989 Apr 1;169(4):1361-71</Citation><ArticleIdList><ArticleId IdType="pubmed">2466942</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Jun;170(2):477-85</Citation><ArticleIdList><ArticleId IdType="pubmed">2658303</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1989 Jul;67(3):375-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2788128</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1989 Sep 1;170(3):763-75</Citation><ArticleIdList><ArticleId IdType="pubmed">2475573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1977 May 26;267(5609):354-6</Citation><ArticleIdList><ArticleId IdType="pubmed">194164</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000381 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000381 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:9765409
|texte= Human cytotoxic T-lymphocyte repertoire to influenza A viruses.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:9765409" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |